Carbetocin

Drug identity checked against registry records

Also recorded as ACP-101

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06173531ACADPhase 3Completed2025-08-19Actual
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06420297ACADPhase 3Terminated2025-12-19Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.